Literature DB >> 17346821

Stent-related cardiac events after non-cardiac surgery: drug-eluting stent vs. bare metal stent.

Hack-Lyoung Kim, Kyung-Woo Park, Jae-Jin Kwak, Yong-Seok Kim, Jung-Ju Sir, Sook-Jin Lee, Hae-Young Lee, Hyuk-Jae Chang, Hyun-Jae Kang, Young-Seok Cho, Woo-Young Chung, In-Ho Chae, Dong-Joo Choi, Hyo-Soo Kim, Byung-Hee Oh, Young-Bae Park, Bon-Kwon Koo.   

Abstract

For evaluation of post-operative stent associated cardiac events after drug-eluting stent (DES) implantation we analyzed data of 138 patients who underwent non-cardiac surgery after DES implantation and compared the data with those of 101 patients who underwent non-cardiac surgery after bare metal stent (BMS) implantation. Three patients (2.2%) in DES group developed post-operative cardiac events and none in BMS group (p=0.2). One patient died due to suspected stent thrombosis and the other two had myocardial infarction due to angiographically proven stent thrombosis. The time interval between stent implantation and surgery in those with cardiac events was 6, 264, and 367 days, respectively. Our data shows that peri-operative stent-related thrombotic complications can occur long after DES implantation and careful peri-operative monitoring for cardiac events is needed in patients receiving non-cardiac surgery after DES implantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17346821     DOI: 10.1016/j.ijcard.2006.11.182

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Drug-eluting stents.

Authors:  Xiaodong Ma; Tim Wu; Michael P Robich; Xingwei Wang; Hao Wu; Bryan Buchholz; Stephen McCarthy
Journal:  Int J Clin Exp Med       Date:  2010-07-15

2.  The management of patients on dual antiplatelet therapy undergoing orthopedic surgery.

Authors:  Han Jo Kim; Lawrence F Levin
Journal:  HSS J       Date:  2010-07-27

Review 3.  The risk of drug-eluting stent thrombosis with noncardiac surgery.

Authors:  Emmanouil S Brilakis; Subhash Banerjee; Peter B Berger
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

4.  Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention.

Authors:  Guo-Hua Zheng; Jian-Ping Liu; Nissi S Wang; Hai-Ying Chen; Jian-Feng Chu
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-16       Impact factor: 2.629

5.  A Nomogram for Predicting In-Hospital Major Adverse Cardio- and Cerebro-Vascular Events in Patients Undergoing Major Noncardiac Surgery: A Large-Scale Nested Case-Control Study.

Authors:  Xuejiao Wu; Jianjun Zhang; Mei Hu; Le Gu; Kuibao Li; Xinchun Yang
Journal:  Ther Clin Risk Manag       Date:  2022-04-22       Impact factor: 2.755

6.  The effects of xuefu zhuyu and shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial.

Authors:  Jie Wang; Xiaochen Yang; Fuyong Chu; Jianxin Chen; Qingyong He; Kuiwu Yao; Fei Teng; Yonghong Gao; Yanhui Xing; Aiming Wu; Yanwei Xing
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-08       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.